Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding
To investigate this hypothesis, we examined the effects of DSA and DSA+DZX cardioplegia on STAT1/3 phosphorylation and DNA binding in the in situ blood perfused pig heart model.
Effect of Platelet-Rich Plasma and Latissimus Dorsi Myofascia With Blood Vessel on Vascularization of Tissue Engineered Bone in Dogs
To study the effect of platelet-rich plasma (PRP) and latissimus dorsi myofascia with blood vessel on vascularization of tissue engineered bone in dogs.
Evaluation of a BED-SIDE Platelet Function Assay: Performance and Clinical Utility
Here we describe a practical, rapid and user-friendly whole blood platelet function assay that has been developed for use in bed-side settings.
Autologous Injectable Tissue-Engineered Cartilage by Using Platelet-Rich Plasma: Experimental Study in a Rabbit Model
This study aimed to investigate the feasibility of a PRP carrier to deliver chondrocytes and regenerate cartilage tissues in a rabbit model via injection.
Cytomedix Receives FDA Clearance for Autologel
Under the supervision of a healthcare professional, the PRP gel produced by the AutoloGel™ System is suitable for exuding wounds, such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgicallydebrided wounds.
Autologous Platelet-Leukocyte Enriched Gel. Basics and Efficacy. A Novel Method to Support Soft Tissue and Bone Healing
The purpose of this thesis was to provide basic information on features which are important for the application of platelet-leukocyte gel, to overcome the conflicting data that have been reported in clinical studies and experimental research on the efficacy of platelet-leukocyte gel treatment.
Early Bone Formation in Human Bone Grafts Treated With Platelet-Rich Plasma: Preliminary Histomorphometric Results
The aim of this study was to evaluate the effect of platelet-rich plasma (PRP) on early and late bone healing after autogenous maxillary sinus grafting.
FDA Panel Votes to Keep Bayer Drug on the Market
A Food and Drug Administration panel of outside medical experts said a Bayer AG drug, used to control bleeding in patients undergoing heart-bypass surgery, should stay on the U.S. market.
Antibacterial Effect of Autologous Platelet Gel Enriched With Growth Factors and Other Active Substances: An In Vitro Study
We analysed the antibacterial effect of platelet-rich gel in vitro by using the platelet-rich plasma samples of 20 volunteers, in vitro laboratory susceptibility to platelet-rich gel was determined by the Kirby-Bauer disc-diffusion method. Baseline antimicrobial activity was assessed by measuring the zones of inhibition on agar plates coated with selected bacterial strains.
Processing of Stored Packed Red Blood Cells Using Autotransfusion Devices Decreases Potassium and Microaggregates: A Prospective, Randomized, Single-Blinded in Vitro Study
The aim of the study was to compare the potential of autotransfusion devices to reduce non-infectious complications related to transfusion of long-stored packed red blood cells (PRBC; n= 57), such as changes in electrolytes, blood cells and the load of free microaggregates.
Prolonged Extracorporeal Membrane Oxygenation-Assisted Support Provides Improved Survival in Hypothermic Patients with Cardiocirculatory Arrest
aim of this study was to evaluate whether extracorporeal membrane oxygenation-assisted resuscitation improves survival in patients with hypothermic cardiac arrest.
Autologous Platelet-Rich Plasma as an Adipocyte In Vivo Delivery System: Case Report
The authors hypothesized that autologous platelet-rich plasma (APRP) could be used as an in vivo adipocyte delivery system to favor cell survival and to stimulate early recruitment of microcapillaries to the site of implantation.